Corcept Therapeutics Inc
F:HTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Corcept Therapeutics Inc
F:HTD
|
US |
|
Afya Ltd
F:1AY
|
BR |
|
John Wiley & Sons Inc
F:2F7
|
US |
|
T
|
TIME dotCom Bhd
KLSE:TIMECOM
|
MY |
|
Vita Coco Company Inc
NASDAQ:COCO
|
US |
|
Luca Mining Corp
XTSX:LUCA
|
CA |
|
S
|
Solaredge Technologies Inc
F:2ED
|
IL |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
XMUN:ME9
|
IT |
|
Unipol Gruppo SpA
F:UIPN
|
IT |
|
P
|
Pool Corp
F:SP1
|
US |
|
A
|
Apollo Investment Corp
F:55O1
|
US |
|
S
|
Swiss Re AG
XMUN:SR9
|
CH |
|
Sasol Ltd
F:SAOA
|
ZA |
|
Impala Platinum Holdings Ltd
F:IPH1
|
ZA |
|
A
|
Aedifica NV
SWB:AOO
|
BE |
|
U
|
United Parcel Service Inc
XMUN:UPAB
|
US |
Bankruptcy Probability
Corcept Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Corcept Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Corcept Therapeutics Inc
NASDAQ:CORT
|
12.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
640B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
369.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
185.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
286.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Corcept Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Corcept Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
